Switching off your appetite for the day is about to be as easy and as pain-free as popping a paracetamol to soothe a niggling ...

Long-defined by high prices, shortages and weekly injections, weight loss drugs including Wegovy and Zepbound are expected to ...

While GLP-1 drugs promise an easy fix, our bodies still need what they have always needed: healthy food and regular exercise, says chair of global public health at the University of Edinburgh, Prof De ...

In some studies, half of patients stopped taking GLP-1s within a year despite the benefits, citing the expense and side ...

Experts say OADs, insulin to dominate anti-diabetes market, with semaglutide patent loss leading to possible price erosion, ...

The global obesity care landscape is on the cusp of a major transformation. The year 2026 is expected to bring in the most powerful generation of anti-obesity medications ever developed. Building on ...

Washington often talks about lowering healthcare costs but ignores one of the simplest ways to do it: addressing the problem of obesity seriously. With the right tools, millions of Americans could ...

With access to unhealthy food soaring and physical activity levels declining, the World Obesity Federation predicts that between 2020 and 2035, Europe and Central Asia will experience a 61% increase ...

Health-care companies rose as traders bet the launch of anti-obesity drug pills would spur pharmaceutical sales. Shares of weight-control drug makers Novo Nordisk and Eli Lilly rose.

Calling obesity a chronic, relapsing disease, Union Minister Dr Jitendra Singh urged caution in the use of weight-loss drugs and warned against misinformation ...

NEW DELHI – Obesity emerged as a central focus of public health policy in India in 2025, driven by a major overhaul of ...

With generic versions of the weight-loss drug Ozempic expected to hit the Canadian market this year, provincial data shows ...